Medtronic buys Covidien for $42.9 billion

Medical device maker Medtronic has agreed to buy rival Covidien for $42.9 billion in a deal that could reduce the firm's tax payments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.